Larotaxel dihydrate
Larotaxel dihydrate (XRP9881 dihydrate) is an orally active and blood-brain barrier penetrant Microtubule stabilizer with an IC50 of 0.21 μM. Larotaxel dihydrate shows activity in Taxane-resistant tumor models. Larotaxel dihydrate exhibits antitumor activity in intracranial glioblastoma models. Larotaxel dihydrate can be used for research on advanced solid tumors.
For research use only. We do not sell to patients.
- CAS No.: 192573-38-9
- Formula: C45H57NO16
- Molecular Weight:867.93
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Larotaxel dihydrate stabilizes microtubules in cell-free assays, preventing cold-induced depolymerization with an IC50 of 0.21 μM[1].
Larotaxel dihydrate shows in vitro activity in various Taxane-resistant tumor models[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 192573-38-9
-
Molecular Weight 867.93
-
Formula C45H57NO16
-
SMILES
O=C([C@]1([H])OC(C)=O)[C@@]23[C@@]([C@@H]([C@@]4(O)C(C)(C)C1=C([C@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C4)C)OC(C6=CC=CC=C6)=O)([H])[C@]7([C@@](OC7)([H])C[C@@H]2C3)OC(C)=O.O.O
-
Synonyms
XRP9881 dihydrate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Larotaxel dihydrate
- 192573-38-9
- XRP9881 dihydrate
- Microtubule/Tubulin
- intracranial glioblastoma models
- P-glycoprotein-expressing multidrug-resistant cancer cells
- taxane-resistant tumor models
- cell cycle arrest
- blood-brain barrier penetration
- microtubule-stabilizing taxane
- cold-induced depolymerization
- mitotic spindle function
- microtubules
- oral activity
- Inhibitor
- inhibitor
- inhibit